AIXN vs PETS
AiXin Life International, Inc. and Petmed Express Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | AIXN | PETS |
|---|---|---|
| Revenue | $1.5M | $179.0M |
| Net income | $-2.0M | $-57.3M |
| Gross margin | 41.7% | 28.1% |
| Net margin | −137.1% | −32.0% |
| Return on equity | · | −100.4% |
| Diluted EPS | −$0.08 | −$2.74 |
| Dividend / share | · | $0.00 |
| Payout ratio | · | −0.0% |
| Free cash flow | $-2.0M | $-33.0M |
| Equity | $-6.6M | $28.9M |
| Net debt / equity | · | · |
| Current ratio | 0.12× | 0.84× |
| Revenue CAGR 5y | −9.5% | −10.0% |
| Profit CAGR 5y | · | · |
PETS bills 120.2× the revenue of AIXN, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | AIXN | PETS |
|---|---|---|
| FY2025 | $1.5M | $179.0M |
| FY2024 | $3.8M | $227.0M |
| FY2023 | $4.1M | $274.1M |
| FY2022 | $2.7M | $247.6M |
| FY2021 | $3.1M | $272.3M |
| FY2020 | $2.5M | $303.6M |
| FY2019 | $3.4M | $284.1M |
| FY2018 | $414,281 | $283.4M |
| FY2017 | $688,095 | $273.8M |
| FY2016 | $3.1M | $249.2M |
Bottom line
| Fiscal year | AIXN | PETS |
|---|---|---|
| FY2025 | $-2.0M | $-57.3M |
| FY2024 | $-2.8M | $-6.3M |
| FY2023 | $-2.1M | $-7.5M |
| FY2022 | $-6.4M | $5.1M |
| FY2021 | $-267,236 | $18.7M |
| FY2020 | $1.0M | $23.9M |
| FY2019 | $1.9M | $25.9M |
| FY2018 | $-1.3M | $37.7M |
| FY2017 | $-4.3M | $37.3M |
| FY2016 | $-2.1M | $23.8M |
13 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −$177,531,573 | PETS |
| FY2024 | −$223,147,699 | PETS |
| FY2023 | −$270,005,201 | PETS |
| FY2022 | −$244,860,440 | PETS |
| FY2021 | −$269,215,767 | PETS |
| FY2020 | −$301,131,945 | PETS |
| FY2019 | −$280,706,792 | PETS |
| FY2018 | −$283,004,719 | PETS |
| FY2017 | −$273,111,905 | PETS |
| FY2016 | −$246,093,275 | PETS |
| FY2014 | −$229,395,000 | PETS |
| FY2013 | −$233,391,000 | PETS |
| FY2012 | −$227,829,000 | PETS |
PETS has reported the higher revenue in every one of these 13 fiscal years. The gap has narrowed since the earliest year compared.
13 of 17 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −105.1 pp | PETS |
| FY2024 | −69.6 pp | PETS |
| FY2023 | −48.4 pp | PETS |
| FY2022 | −237.2 pp | PETS |
| FY2021 | −15.6 pp | PETS |
| FY2020 | +33.6 pp | AIXN |
| FY2019 | +46.3 pp | AIXN |
| FY2018 | −339.1 pp | PETS |
| FY2017 | −632.0 pp | PETS |
| FY2016 | −77.0 pp | PETS |
The higher net margin has changed hands between AIXN and PETS over this period.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
AIXN's net margin has been more volatile than PETS's over the 10 comparable fiscal years — 194.6 percentage points of standard deviation against 12.8.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between AIXN and PETS over these 10 fiscal years — AIXN led in 2 and PETS in 8.
10 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
AIXN's return on equity has been more volatile than PETS's over the 3 comparable fiscal years — 64.6 percentage points of standard deviation against 2.7.
3 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
PETS led in return on equity in every one of the 3 comparable fiscal years — a structural lead, not a recent swing.
3 of 17 comparable fiscal years — a year missing data on either side is not counted.